| regulation of feeding behavior | GO:0060259 | 3 | 0.624 | |
| response to testosterone | GO:0033574 | 3 | 0.558 | |
| muscle atrophy | GO:0014889 | 3 | 0.531 | |
| regulation of protein deacetylation | GO:0090311 | 17 | 0.408 | |
| activation induced cell death of t cells | GO:0006924 | 10 | 0.371 | |
| positive regulation of leukocyte apoptotic process | GO:2000108 | 21 | 0.361 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.325 | |
| positive regulation of t cell apoptotic process | GO:0070234 | 8 | 0.319 | |
| regulation of binding | GO:0051098 | 111 | 0.316 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.301 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.289 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.280 | |
| amine metabolic process | GO:0009308 | 45 | 0.263 | |
| interleukin 17 production | GO:0032620 | 11 | 0.251 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.236 | |
| positive regulation of protein acetylation | GO:1901985 | 9 | 0.222 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.222 | |
| cation transport | GO:0006812 | 399 | 0.214 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.213 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.211 | |
| adaptive immune response | GO:0002250 | 155 | 0.207 | |
| defense response to bacterium | GO:0042742 | 119 | 0.202 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.199 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.197 | |
| t cell differentiation | GO:0030217 | 174 | 0.190 | |
| striated muscle atrophy | GO:0014891 | 2 | 0.187 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.185 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.184 | |
| regulation of histone deacetylation | GO:0031063 | 12 | 0.184 | |
| kidney development | GO:0001822 | 213 | 0.180 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.176 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.175 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.175 | |
| t cell activation | GO:0042110 | 289 | 0.172 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.172 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.171 | |
| regulation of cell activation | GO:0050865 | 289 | 0.168 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.161 | |
| regionalization | GO:0003002 | 337 | 0.161 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.158 | |
| t cell apoptotic process | GO:0070231 | 39 | 0.156 | |
| urogenital system development | GO:0001655 | 261 | 0.156 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.155 | |
| muscle adaptation | GO:0043500 | 39 | 0.153 | |
| kidney epithelium development | GO:0072073 | 121 | 0.151 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.151 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.148 | |
| dopamine metabolic process | GO:0042417 | 23 | 0.147 | |
| regulation of cell growth | GO:0001558 | 91 | 0.147 | |
| cytokine production | GO:0001816 | 319 | 0.146 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.143 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.142 | |
| t cell proliferation | GO:0042098 | 120 | 0.139 | |
| chromatin organization | GO:0006325 | 206 | 0.134 | |
| regulation of protein transport | GO:0051223 | 163 | 0.134 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.134 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.132 | |
| ureteric bud development | GO:0001657 | 94 | 0.131 | |
| phenol containing compound biosynthetic process | GO:0046189 | 21 | 0.131 | |
| renal system development | GO:0072001 | 225 | 0.129 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.125 | |
| positive regulation of lymphocyte apoptotic process | GO:0070230 | 13 | 0.125 | |
| regulation of sodium ion transport | GO:0002028 | 29 | 0.125 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.122 | |
| mesonephros development | GO:0001823 | 97 | 0.119 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 22 | 0.118 | |
| regulation of protein localization | GO:0032880 | 231 | 0.117 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.117 | |
| cell cycle arrest | GO:0007050 | 37 | 0.117 | |
| histone deacetylation | GO:0016575 | 26 | 0.116 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.115 | |
| wound healing | GO:0042060 | 157 | 0.112 | |
| defense response to other organism | GO:0098542 | 197 | 0.112 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.111 | |
| muscle system process | GO:0003012 | 141 | 0.110 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.110 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.110 | |
| intracellular protein transport | GO:0006886 | 204 | 0.110 | |
| skeletal system development | GO:0001501 | 356 | 0.109 | |
| negative regulation of growth | GO:0045926 | 99 | 0.108 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.107 | |
| cell fate commitment | GO:0045165 | 210 | 0.107 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.107 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.105 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.103 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.102 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.102 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.102 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.101 | |
| negative regulation of t cell proliferation | GO:0042130 | 38 | 0.101 | |
| stem cell differentiation | GO:0048863 | 268 | 0.100 | |
| regulation of ion transport | GO:0043269 | 215 | 0.099 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.098 | |
| spinal cord development | GO:0021510 | 81 | 0.098 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.097 | |
| head morphogenesis | GO:0060323 | 34 | 0.095 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.095 | |
| spinal cord patterning | GO:0021511 | 25 | 0.093 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.091 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.090 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.090 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.089 | |
| positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001241 | 10 | 0.089 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.088 | |
| histone modification | GO:0016570 | 159 | 0.088 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.088 | |
| skin development | GO:0043588 | 220 | 0.088 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.088 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.087 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.087 | |
| muscle tissue development | GO:0060537 | 308 | 0.087 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.087 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.086 | |
| axonogenesis | GO:0007409 | 274 | 0.086 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.086 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.085 | |
| positive regulation of stem cell differentiation | GO:2000738 | 23 | 0.084 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.084 | |
| skin morphogenesis | GO:0043589 | 38 | 0.084 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.083 | |
| connective tissue development | GO:0061448 | 179 | 0.082 | |
| protein deacetylation | GO:0006476 | 32 | 0.082 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.082 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.081 | |
| protein deacylation | GO:0035601 | 36 | 0.080 | |
| pathway restricted smad protein phosphorylation | GO:0060389 | 10 | 0.080 | |
| gland development | GO:0048732 | 330 | 0.080 | |
| tolerance induction to self antigen | GO:0002513 | 4 | 0.080 | |
| protein import into nucleus | GO:0006606 | 95 | 0.080 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.078 | |
| regulation of interleukin 17 production | GO:0032660 | 8 | 0.078 | |
| extracellular structure organization | GO:0043062 | 148 | 0.078 | |
| cation homeostasis | GO:0055080 | 212 | 0.078 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.078 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.077 | |
| positive regulation of histone acetylation | GO:0035066 | 8 | 0.077 | |
| lymph node development | GO:0048535 | 18 | 0.076 | |
| chromatin modification | GO:0016568 | 187 | 0.076 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.075 | |
| histone acetylation | GO:0016573 | 41 | 0.073 | |
| cell growth | GO:0016049 | 130 | 0.073 | |
| chemotaxis | GO:0006935 | 247 | 0.073 | |
| inflammatory response | GO:0006954 | 244 | 0.073 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.073 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.073 | |
| response to dexamethasone | GO:0071548 | 8 | 0.073 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.072 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.071 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.071 | |
| actin cytoskeleton reorganization | GO:0031532 | 21 | 0.071 | |
| mesenchyme development | GO:0060485 | 152 | 0.071 | |
| protein acylation | GO:0043543 | 64 | 0.071 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.070 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.070 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.069 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.068 | |
| defense response to gram negative bacterium | GO:0050829 | 28 | 0.068 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.067 | |
| heart valve development | GO:0003170 | 23 | 0.066 | |
| ovulation cycle | GO:0042698 | 59 | 0.066 | |
| response to heat | GO:0009408 | 27 | 0.066 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.066 | |
| positive regulation of extrinsic apoptotic signaling pathway | GO:2001238 | 34 | 0.065 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.065 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.065 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.064 | |
| muscle fiber development | GO:0048747 | 76 | 0.064 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.064 | |
| rhythmic process | GO:0048511 | 174 | 0.064 | |
| developmental maturation | GO:0021700 | 193 | 0.064 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.063 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.063 | |
| single organism nuclear import | GO:1902593 | 95 | 0.062 | |
| regulation of ossification | GO:0030278 | 112 | 0.062 | |
| regulation of protein import into nucleus | GO:0042306 | 52 | 0.062 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.062 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.062 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.062 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.062 | |
| positive regulation of protein deacetylation | GO:0090312 | 9 | 0.061 | |
| pancreas development | GO:0031016 | 57 | 0.061 | |
| protein targeting | GO:0006605 | 143 | 0.061 | |
| striated muscle adaptation | GO:0014888 | 26 | 0.061 | |
| cartilage development | GO:0051216 | 140 | 0.060 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.060 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.060 | |
| molting cycle | GO:0042303 | 90 | 0.059 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.058 | |
| cell division | GO:0051301 | 120 | 0.058 | |
| regulation of peptidyl lysine acetylation | GO:2000756 | 22 | 0.058 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.057 | |
| stem cell development | GO:0048864 | 219 | 0.057 | |
| regulation of system process | GO:0044057 | 200 | 0.057 | |
| myeloid dendritic cell activation | GO:0001773 | 25 | 0.056 | |
| positive regulation of epithelial to mesenchymal transition | GO:0010718 | 13 | 0.056 | |
| cellular response to lipid | GO:0071396 | 145 | 0.056 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.056 | |
| regulation of odontogenesis | GO:0042481 | 18 | 0.055 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.055 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.055 | |
| face morphogenesis | GO:0060325 | 29 | 0.055 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.055 | |
| ossification | GO:0001503 | 216 | 0.055 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.054 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.054 | |
| collagen metabolic process | GO:0032963 | 17 | 0.054 | |
| epithelial to mesenchymal transition | GO:0001837 | 47 | 0.053 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.052 | |
| regulation of histone modification | GO:0031056 | 56 | 0.052 | |
| regulation of muscle hypertrophy | GO:0014743 | 13 | 0.052 | |
| regulation of protein binding | GO:0043393 | 60 | 0.052 | |
| protein localization to organelle | GO:0033365 | 185 | 0.051 | |
| hair cycle | GO:0042633 | 90 | 0.051 | |
| muscle hypertrophy | GO:0014896 | 24 | 0.051 | |
| nuclear transport | GO:0051169 | 139 | 0.051 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.050 | |
| regulation of histone acetylation | GO:0035065 | 19 | 0.050 | |
| endoderm development | GO:0007492 | 45 | 0.050 | |
| collagen biosynthetic process | GO:0032964 | 7 | 0.049 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.049 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.048 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.048 | |
| dopamine biosynthetic process | GO:0042416 | 6 | 0.048 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.047 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.047 | |
| negative regulation of leukocyte proliferation | GO:0070664 | 46 | 0.047 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.046 | |
| development of secondary female sexual characteristics | GO:0046543 | 8 | 0.046 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.045 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.045 | |
| skeletal muscle tissue regeneration | GO:0043403 | 20 | 0.045 | |
| branching involved in mammary gland duct morphogenesis | GO:0060444 | 27 | 0.045 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 33 | 0.045 | |
| feeding behavior | GO:0007631 | 62 | 0.045 | |
| negative regulation of lymphocyte proliferation | GO:0050672 | 45 | 0.045 | |
| regulation of t cell apoptotic process | GO:0070232 | 28 | 0.045 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.044 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.044 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.044 | |
| hair follicle development | GO:0001942 | 85 | 0.043 | |
| ear morphogenesis | GO:0042471 | 118 | 0.043 | |
| negative regulation of muscle hypertrophy | GO:0014741 | 9 | 0.043 | |
| eating behavior | GO:0042755 | 15 | 0.043 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.043 | |
| camera type eye development | GO:0043010 | 266 | 0.043 | |
| metanephros development | GO:0001656 | 79 | 0.043 | |
| ear development | GO:0043583 | 200 | 0.043 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.042 | |
| negative regulation of dna binding | GO:0043392 | 20 | 0.042 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.042 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.042 | |
| protein import | GO:0017038 | 101 | 0.041 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.041 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.039 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.039 | |
| axis elongation | GO:0003401 | 30 | 0.039 | |
| multicellular organismal macromolecule metabolic process | GO:0044259 | 19 | 0.039 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.039 | |
| neuron projection guidance | GO:0097485 | 141 | 0.039 | |
| regeneration | GO:0031099 | 38 | 0.038 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.038 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.037 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 26 | 0.037 | |
| cell maturation | GO:0048469 | 127 | 0.037 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.037 | |
| nuclear import | GO:0051170 | 95 | 0.036 | |
| negative regulation of binding | GO:0051100 | 39 | 0.036 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.036 | |
| branch elongation of an epithelium | GO:0060602 | 19 | 0.036 | |
| multicellular organismal metabolic process | GO:0044236 | 28 | 0.036 | |
| skeletal muscle adaptation | GO:0043501 | 16 | 0.036 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.036 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.036 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.036 | |
| locomotory behavior | GO:0007626 | 195 | 0.035 | |
| organelle assembly | GO:0070925 | 177 | 0.034 | |
| positive regulation of protein localization to nucleus | GO:1900182 | 30 | 0.034 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.034 | |
| regulation of activation induced cell death of t cells | GO:0070235 | 6 | 0.034 | |
| response to growth factor | GO:0070848 | 198 | 0.034 | |
| cell aggregation | GO:0098743 | 18 | 0.033 | |
| transmembrane transport | GO:0055085 | 412 | 0.033 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.032 | |
| microtubule based movement | GO:0007018 | 84 | 0.032 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.032 | |
| tolerance induction | GO:0002507 | 14 | 0.032 | |
| heart valve morphogenesis | GO:0003179 | 21 | 0.032 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.032 | |
| cellular response to ketone | GO:1901655 | 12 | 0.031 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.031 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.031 | |
| negative regulation of cartilage development | GO:0061037 | 17 | 0.031 | |
| regulatory t cell differentiation | GO:0045066 | 10 | 0.030 | |
| somatic stem cell division | GO:0048103 | 19 | 0.030 | |
| regulation of protein acetylation | GO:1901983 | 22 | 0.030 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.030 | |
| mammary gland branching involved in thelarche | GO:0060744 | 6 | 0.030 | |
| cartilage condensation | GO:0001502 | 18 | 0.030 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.030 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.029 | |
| regulation of cell cycle arrest | GO:0071156 | 12 | 0.029 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.029 | |
| extracellular matrix assembly | GO:0085029 | 12 | 0.029 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.029 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.029 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.028 | |
| cellular response to glucocorticoid stimulus | GO:0071385 | 13 | 0.028 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.028 | |
| positive regulation of histone deacetylation | GO:0031065 | 7 | 0.027 | |
| negative regulation of muscle tissue development | GO:1901862 | 20 | 0.027 | |
| catecholamine biosynthetic process | GO:0042423 | 11 | 0.026 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.026 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.026 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.026 | |
| regulation of protein localization to nucleus | GO:1900180 | 60 | 0.025 | |
| circulatory system process | GO:0003013 | 197 | 0.025 | |
| cytoskeleton dependent intracellular transport | GO:0030705 | 50 | 0.025 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.025 | |
| lipid transport | GO:0006869 | 98 | 0.025 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.025 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.024 | |
| regulation of branching involved in mammary gland duct morphogenesis | GO:0060762 | 6 | 0.024 | |
| protein ubiquitination | GO:0016567 | 171 | 0.024 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.023 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.023 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.023 | |
| regulation of multicellular organismal metabolic process | GO:0044246 | 14 | 0.023 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.023 | |
| microtubule based process | GO:0007017 | 236 | 0.022 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.022 | |
| regulation of extracellular matrix organization | GO:1903053 | 11 | 0.022 | |
| odontogenesis | GO:0042476 | 78 | 0.021 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.021 | |
| amide transport | GO:0042886 | 138 | 0.021 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.021 | |
| tissue regeneration | GO:0042246 | 22 | 0.021 | |
| face development | GO:0060324 | 38 | 0.021 | |
| regulation of ovulation | GO:0060278 | 3 | 0.021 | |
| cellular response to corticosteroid stimulus | GO:0071384 | 13 | 0.021 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.021 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.021 | |
| dendritic cell differentiation | GO:0097028 | 26 | 0.021 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.021 | |
| response to ethanol | GO:0045471 | 18 | 0.020 | |
| positive regulation of peptidyl lysine acetylation | GO:2000758 | 9 | 0.020 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.020 | |
| interleukin 8 production | GO:0032637 | 4 | 0.020 | |
| male gamete generation | GO:0048232 | 285 | 0.020 | |
| blood vessel remodeling | GO:0001974 | 33 | 0.020 | |
| regulation of morphogenesis of a branching structure | GO:0060688 | 53 | 0.020 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.020 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.020 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.020 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.019 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.019 | |
| development of secondary sexual characteristics | GO:0045136 | 11 | 0.019 | |
| branch elongation involved in mammary gland duct branching | GO:0060751 | 6 | 0.019 | |
| body morphogenesis | GO:0010171 | 45 | 0.019 | |
| response to radiation | GO:0009314 | 165 | 0.019 | |
| axon guidance | GO:0007411 | 141 | 0.019 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.019 | |
| sodium ion transport | GO:0006814 | 73 | 0.018 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.018 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.018 | |
| microtubule based transport | GO:0010970 | 50 | 0.018 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.018 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.018 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.018 | |
| organelle localization | GO:0051640 | 179 | 0.018 | |
| negative regulation of protein binding | GO:0032091 | 17 | 0.018 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.018 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.017 | |
| otic placode formation | GO:0043049 | 1 | 0.017 | |
| negative regulation of striated muscle tissue development | GO:0045843 | 18 | 0.017 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.017 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.017 | |
| regulation of actin cytoskeleton reorganization | GO:2000249 | 9 | 0.017 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.017 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.017 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.017 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.017 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.016 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.016 | |
| striated muscle cell development | GO:0055002 | 125 | 0.016 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.016 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.016 | |
| methylation | GO:0032259 | 134 | 0.016 | |
| maintenance of location | GO:0051235 | 89 | 0.016 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.016 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.016 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.016 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.016 | |
| response to light stimulus | GO:0009416 | 135 | 0.016 | |
| response to alcohol | GO:0097305 | 48 | 0.016 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.016 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.016 | |
| response to estrogen | GO:0043627 | 24 | 0.016 | |
| spermatogenesis | GO:0007283 | 284 | 0.016 | |
| endomembrane system organization | GO:0010256 | 147 | 0.016 | |
| oxidation reduction process | GO:0055114 | 342 | 0.016 | |
| mitochondrion organization | GO:0007005 | 134 | 0.016 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.015 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.015 | |
| cellular homeostasis | GO:0019725 | 240 | 0.015 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.015 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.015 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.015 | |
| positive regulation of collagen biosynthetic process | GO:0032967 | 6 | 0.015 | |
| hexose metabolic process | GO:0019318 | 98 | 0.015 | |
| palate development | GO:0060021 | 76 | 0.015 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.015 | |
| protein maturation | GO:0051604 | 176 | 0.015 | |
| sensory perception | GO:0007600 | 245 | 0.015 | |
| cell adhesion | GO:0007155 | 329 | 0.015 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.015 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.015 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.015 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.015 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.015 | |
| anion transport | GO:0006820 | 177 | 0.015 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.015 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.015 | |
| negative regulation of activin receptor signaling pathway | GO:0032926 | 6 | 0.014 | |
| spermatid development | GO:0007286 | 108 | 0.014 | |
| response to nutrient levels | GO:0031667 | 109 | 0.014 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.014 | |
| positive regulation of odontogenesis | GO:0042482 | 4 | 0.014 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.014 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.014 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.014 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.014 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.014 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.014 | |
| response to ketone | GO:1901654 | 15 | 0.014 | |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.014 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.014 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.014 | |
| germ cell development | GO:0007281 | 185 | 0.014 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.014 | |
| regulation of secretion | GO:0051046 | 274 | 0.014 | |
| female sex differentiation | GO:0046660 | 84 | 0.014 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.014 | |
| macromolecule methylation | GO:0043414 | 120 | 0.013 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.013 | |
| response to muscle inactivity | GO:0014870 | 4 | 0.013 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.013 | |
| response to sterol | GO:0036314 | 4 | 0.013 | |
| nuclear division | GO:0000280 | 158 | 0.013 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.013 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.013 | |
| relaxation of muscle | GO:0090075 | 18 | 0.013 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.013 | |
| b cell activation | GO:0042113 | 161 | 0.013 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.013 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.013 | |
| epidermis development | GO:0008544 | 187 | 0.013 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.013 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.013 | |
| synaptic transmission | GO:0007268 | 329 | 0.013 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.013 | |
| negative regulation of cytoskeleton organization | GO:0051494 | 36 | 0.013 | |
| epithelial cell development | GO:0002064 | 159 | 0.013 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.013 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.013 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.013 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.012 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.012 | |
| segmentation | GO:0035282 | 93 | 0.012 | |
| digestive system development | GO:0055123 | 200 | 0.012 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.012 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.012 | |
| response to steroid hormone | GO:0048545 | 56 | 0.012 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.012 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.012 | |
| positive regulation of collagen metabolic process | GO:0010714 | 6 | 0.012 | |
| action potential | GO:0001508 | 78 | 0.012 | |
| response to starvation | GO:0042594 | 65 | 0.012 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.012 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.012 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.012 | |
| germ cell migration | GO:0008354 | 8 | 0.012 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.012 | |
| compound eye development | GO:0048749 | 1 | 0.012 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.012 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.012 | |
